Back to Capital World Investors Capital World Investors

GILDGILD
Showing 8 of 29 quarters

Position history for Capital World InvestorsCapital World Investors's holdings in GILEAD SCIENCES INC

Yes. Capital World Investors holds 40,988,975 shares of GILD (Gilead Sciences), worth $5.2B, as of its Q2 2026 13F filing. It reduced the position by 294,958 shares (-0.7%) from Q1 2026. Capital World Investors has held GILD in every 13F on record since Q2 2019, 29 quarterly filings. GILD is 0.6% of Capital World Investors' reported 13F portfolio.

Current Value

$5.2B

Current Shares

41M

Total Value Change

-$1.2B

Total Shares Change

-35.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
41M
-0.7%
$5.2B0.6%$125.63
0
2026-Q1
Decreased
41.3M
-3.7%
$5.8B0.8%$137.68
0
2025-Q4
Decreased
42.9M
-5.1%
$5.3B0.7%$120.57
0
2025-Q3
Decreased
45.2M
-2.4%
$5B0.7%$108.32
0
2025-Q2
Decreased
46.3M
-13.5%
$5.1B0.7%$107.45
0
2025-Q1
Decreased
53.5M
-25.3%
$6B1.0%$107.83
0
2024-Q4
Decreased
71.7M
-6.3%
$6.6B1.0%$88.27
0
2024-Q3
Increased
76.5M
+0.4%
$6.4B1.0%$79.45
45

Other major holders of GILD: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used